Literature DB >> 35423143

Research developments in the syntheses, anti-inflammatory activities and structure-activity relationships of pyrimidines.

Haroon Ur Rashid1,2, Marco Antonio Utrera Martines1, Adriana Pereira Duarte1, Juliana Jorge1, Shagufta Rasool2, Riaz Muhammad2, Nasir Ahmad3, Muhammad Naveed Umar4.   

Abstract

Pyrimidines are aromatic heterocyclic compounds that contain two nitrogen atoms at positions 1 and 3 of the six-membered ring. Numerous natural and synthetic pyrimidines are known to exist. They display a range of pharmacological effects including antioxidants, antibacterial, antiviral, antifungal, antituberculosis, and anti-inflammatory. This review sums up recent developments in the synthesis, anti-inflammatory effects, and structure-activity relationships (SARs) of pyrimidine derivatives. Numerous methods for the synthesis of pyrimidines are described. Anti-inflammatory effects of pyrimidines are attributed to their inhibitory response versus the expression and activities of certain vital inflammatory mediators namely prostaglandin E2, inducible nitric oxide synthase, tumor necrosis factor-α, nuclear factor κB, leukotrienes, and some interleukins. Literature studies reveal that a large number of pyrimidines exhibit potent anti-inflammatory effects. SARs of numerous pyrimidines have been discussed in detail. Several possible research guidelines and suggestions for the development of new pyrimidines as anti-inflammatory agents are also given. Detailed SAR analysis and prospects together provide clues for the synthesis of novel pyrimidine analogs possessing enhanced anti-inflammatory activities with minimum toxicity. This journal is © The Royal Society of Chemistry.

Entities:  

Year:  2021        PMID: 35423143      PMCID: PMC8694831          DOI: 10.1039/d0ra10657g

Source DB:  PubMed          Journal:  RSC Adv        ISSN: 2046-2069            Impact factor:   3.361


  107 in total

Review 1.  Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications.

Authors:  Sam Harirforoosh; Waheed Asghar; Fakhreddin Jamali
Journal:  J Pharm Pharm Sci       Date:  2013       Impact factor: 2.327

2.  Synthesis, evaluation and docking of novel pyrazolo pyrimidines as potent p38α MAP kinase inhibitors with improved anti-inflammatory, ulcerogenic and TNF-α inhibitory properties.

Authors:  Kanagasabai Somakala; Sana Tariq; Mohd Amir
Journal:  Bioorg Chem       Date:  2019-03-15       Impact factor: 5.275

3.  New quinazolinone-pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies.

Authors:  Safinaz E Abbas; Fadi M Awadallah; Nashwa A Ibrahin; Eman G Said; Gihan M Kamel
Journal:  Eur J Med Chem       Date:  2012-04-09       Impact factor: 6.514

4.  Novel thieno[2,3-d]pyrimidines: their design, synthesis, crystal structure analysis and pharmacological evaluation.

Authors:  Raju Adepu; D Rambabu; Bagineni Prasad; Chandana Lakshmi T Meda; Ajit Kandale; G Rama Krishna; C Malla Reddy; Lakshmi N Chennuru; Kishore V L Parsa; Manojit Pal
Journal:  Org Biomol Chem       Date:  2012-06-19       Impact factor: 3.876

Review 5.  Anti-inflammatory agents from plants: progress and potential.

Authors:  M C Recio; I Andujar; J L Rios
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

6.  Iron Catalysis for Modular Pyrimidine Synthesis through β-Ammoniation/Cyclization of Saturated Carbonyl Compounds with Amidines.

Authors:  Xue-Qiang Chu; Wen-Bin Cao; Xiao-Ping Xu; Shun-Jun Ji
Journal:  J Org Chem       Date:  2017-01-09       Impact factor: 4.354

Review 7.  Phosphodiesterase 4 inhibitors for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs.

Authors:  Aaron M Mulhall; Christopher A Droege; Neil E Ernst; Ralph J Panos; Muhammad A Zafar
Journal:  Expert Opin Investig Drugs       Date:  2015-09-30       Impact factor: 6.206

8.  Novel heterocycle-substituted pyrimidines as inhibitors of NF-kappaB transcription regulation related to TNF-alpha cytokine release.

Authors:  Hyung-Ho Ha; Jee Seon Kim; B Moon Kim
Journal:  Bioorg Med Chem Lett       Date:  2007-11-22       Impact factor: 2.823

9.  Pyrimidine-based fluorescent COX-2 inhibitors: synthesis and biological evaluation.

Authors:  Ole Tietz; Jatinder Kaur; Atul Bhardwaj; Frank R Wuest
Journal:  Org Biomol Chem       Date:  2016-07-26       Impact factor: 3.876

10.  Design and synthesis of novel pyrazolo[4,3-d]pyrimidines as potential therapeutic agents for acute lung injury.

Authors:  Bao Shi Wang; Xin Huang; Liu Zeng Chen; Ming Ming Liu; Jing Bo Shi
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

View more
  4 in total

Review 1.  Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors.

Authors:  Mohsen Ahmadi; Sander Bekeschus; Klaus-Dieter Weltmann; Thomas von Woedtke; Kristian Wende
Journal:  RSC Med Chem       Date:  2022-02-14

Review 2.  Ultrasound-assisted transition-metal-free catalysis: a sustainable route towards the synthesis of bioactive heterocycles.

Authors:  Biplob Borah; L Raju Chowhan
Journal:  RSC Adv       Date:  2022-05-11       Impact factor: 4.036

3.  Novel pyrrolopyrimidine derivatives: design, synthesis, molecular docking, molecular simulations and biological evaluations as antioxidant and anti-inflammatory agents.

Authors:  Amira I Sayed; Yara E Mansour; Mohamed A Ali; Omnia Aly; Zainab M Khoder; Ahmed M Said; Samar S Fatahala; Rania H Abd El-Hameed
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

4.  Ultrasensitive and Specific Detection of Anticancer Drug 5-Fluorouracil in Blood Samples by a Surface-Enhanced Raman Scattering (SERS)-Based Lateral Flow Immunochromatographic Assay.

Authors:  Hanwen Liu; Ying Liu; Ting Zhou; Penghui Zhou; Jianguo Li; Anping Deng
Journal:  Molecules       Date:  2022-06-22       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.